Honduras vs Paraguay: Antiretroviral therapy coverage for PMTCT
Honduras
42.0%
in 2024
Paraguay
52.0%
in 2024
Honduras rank
70th
Paraguay rank
67th
Antiretroviral therapy coverage for PMTCT over time
- Honduras
- Paraguay
How they compare
Paraguay currently reports 52.0% against 42.0% in Honduras, a difference of 10.0%.
That makes Paraguay's figure about 1.2 times Honduras's.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Paraguay ahead.
Honduras ranks 70th and Paraguay ranks 67th of 84 countries.
Paraguay has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Honduras | Paraguay | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 13.6% | 30.4% | 16.8% | Paraguay |
| 2010s | 45.1% | 71.6% | 26.5% | Paraguay |
| 2020s | 43.6% | 66.4% | 22.8% | Paraguay |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Honduras or Paraguay?
- Paraguay, at 52.0% against 42.0% in Honduras as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Honduras and Paraguay?
- 10.0%, with Paraguay ahead.
- How many years of comparable data are there for Honduras and Paraguay?
- 25 years are reported by both, from 2000 to 2024.
- How do Honduras and Paraguay rank globally for antiretroviral therapy coverage for pmtct?
- Honduras ranks 70th and Paraguay ranks 67th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).